Breakthroughs in global health science flourish in 2010
Last year was marked by monumental progress in science and research for global health. Dramatic progress was announced in the development of new vaccines, microbicides, diagnostic tools, drugs, and other products for a range of global health diseases—from HIV, tuberculosis (TB), malaria, and neglected tropical diseases. The GHTC has compiled a list of the top five innovations in global health from 2010.
Read more 
New evidence shows that global health research is a smart choice for the US
Investing in global health research is a wise investment for the US government that can reap benefits both at home and abroad. In an effort to demonstrate the domestic advantages of investments in science and innovation, Research!America recently launched an initiative to highlight the economic benefits of global health research in specific US states, starting with Illinois.
Read more
Agency spotlight: BARDA
The Biomedical Advanced Research and Development Authority (BARDA) funds the development and purchase of vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies, including global health diseases. BARDA manages Project BioShield, which funds the procurement and development of medical tools for pandemic influenza and other emerging infectious diseases.
Read more about BARDA and global health product development
Visit the BARDA website
Photos (top to bottom): Mike Wang, Wendy Stone, Satvir Malhotra
|
 |
|
|
January 2011
UPCOMING EVENTS
February 15, 2011
Addressing grand challenges: The role of science in global health development by USAID Administrator Rajiv Shah
February 17-21, 2011
The American Association for the Advancement of Science annual meeting
NEW AND NOTEWORTHY
USAID Administrator Shah outlines agency’s plans to modernize foreign aid, harness science and innovation
Find GHTC members on social media
Vaccines are ‘among the greatest scientific contributions to human welfare,’ opinion piece says
Experimental malaria vaccine shows sustained efficacy
Group of public health research funders calls for widespread sharing of data
Incentives to spur global health research and delivery are working, blog says
Increasing number of nonprofit, for-profit pharmaceutical companies partnering to advance global health drug development
New report finds increasing commitment to research from developing countries
MEMBER FOCUS
GHTC member the International AIDS Vaccine Initiative (IAVI) has released a new publication that offers US policy recommendations for advancing HIV/AIDS vaccine development. The publication outlines four key policy priorities for vaccine development: sustaining funding, elevating research in US international development policy, leading on innovative financing mechanisms for global health research, and promoting coordinated regulatory systems.
Read more
Read an IAVI blog post about global health research |
|
Received this as a forward? Click here to sign up for future issues.
If you wish to unsubscribe, please click here to send us a message. We will remove your name from our mailing list as soon as possible.
The Global Health Technologies Coalition (GHTC) is a group of more than 30 nonprofit organizations working to increase awareness of the urgent need for tools that save lives in the developing world. These tools include new vaccines, drugs, microbicides, diagnostic tests, and other devices. The coalition advocates for increased and effective use of public resources, incentives to encourage private investment, and improved regulatory systems. Learn more at www.ghtcoalition.org.
To see a list of GHTC members, click here.
We respect the privacy of our online relationships. our mailing lists are never sold to third parties. We will only share personally identifiable information with third parties when the person submitting the information authorizes us to share it or we are required to by law. |